155 related articles for article (PubMed ID: 1627795)
1. Morphology in patients with severe aplastic anemia treated with antilymphocyte globulin.
Tichelli A; Gratwohl A; Nissen C; Signer E; Stebler Gysi C; Speck B
Blood; 1992 Jul; 80(2):337-45. PubMed ID: 1627795
[TBL] [Abstract][Full Text] [Related]
2. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome.
Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A
Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157
[TBL] [Abstract][Full Text] [Related]
3. Late clonal complications in severe aplastic anemia.
Tichelli A; Gratwohl A; Nissen C; Speck B
Leuk Lymphoma; 1994 Jan; 12(3-4):167-75. PubMed ID: 8167549
[TBL] [Abstract][Full Text] [Related]
4. Special Education: Aplastic Anemia.
Teramura M; Mizoguchi H
Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
[TBL] [Abstract][Full Text] [Related]
5. A comparison between ALG and bone marrow transplantation in treatment of severe aplastic anemia.
Speck B; Gratwohl A; Nissen C; Osterwalder B; Würsch A; Tichelli A; Lori A; Reusser P; Jeannet M; Signer E
Thymus; 1987; 10(1-2):147-58. PubMed ID: 3324403
[TBL] [Abstract][Full Text] [Related]
6. [Stimulation of hematopoietic stem cells by antilymphocyte serum].
Gluckman E; Devergie A; Barrett J; Faille A
C R Acad Hebd Seances Acad Sci D; 1977 Oct; 285(7):841-3. PubMed ID: 411591
[TBL] [Abstract][Full Text] [Related]
7. [Late complications in patients with aplastic anemia].
Tichelli A; Gratwohl A; Nissen C; Würsch A; Signer E; Speck B
Schweiz Med Wochenschr; 1988 Oct; 118(42):1528-32. PubMed ID: 3059487
[TBL] [Abstract][Full Text] [Related]
8. Complete recovery of marrow function after treatment with anti-lymphocyte globulin is associated with high, whereas early failure and development of paroxysmal nocturnal haemoglobinuria are associated with low endogenous G-CSA-release.
Nissen C; Moser Y; dalle Carbonare V; Gratwohl A; Speck B
Br J Haematol; 1989 Aug; 72(4):573-7. PubMed ID: 2789075
[TBL] [Abstract][Full Text] [Related]
9. Late haematological complications in severe aplastic anaemia.
Tichelli A; Gratwohl A; Würsch A; Nissen C; Speck B
Br J Haematol; 1988 Jul; 69(3):413-8. PubMed ID: 3044440
[TBL] [Abstract][Full Text] [Related]
10. High incidence of transiently appearing complement-sensitive bone marrow precursor cells in patients with severe aplastic anemia--A possible role of high endogenous IL-2 in their suppression.
Nissen C; Tichelli A; Gratwohl A; Warthmann C; Moser Y; dalle Carbonare V; Sendelov S; Chklovskaia E; Jansen W; Wodnar-Filipowicz A; Sadallah S; Speck B
Acta Haematol; 1999; 101(4):165-72. PubMed ID: 10436296
[TBL] [Abstract][Full Text] [Related]
11. Persistent growth impairment of bone marrow stroma after antilymphocyte globulin treatment for severe aplastic anaemia and its association with relapse.
Nissen C; Wodnar-Filipowicz A; Slanicka Krieger MS; Slanicka Gratwohl A; Tichelli A; Speck B
Eur J Haematol; 1995 Oct; 55(4):255-61. PubMed ID: 7589344
[TBL] [Abstract][Full Text] [Related]
12. Immune suppression therapy in aplastic anemia: influencing factors on response and survival.
Jin JY; Kim DW; Lee JW; Han CW; Min WS; Park CW; Kim CC; Kim DJ; Kim HK; Song HH
Korean J Intern Med; 1995 Jan; 10(1):25-31. PubMed ID: 7626553
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow histopathology of patients with severe aplastic anaemia before treatment and at follow-up.
de Planque MM; van Krieken JH; Kluin-Nelemans HC; Colla LP; van der Burgh F; Brand A; Kluin PM
Br J Haematol; 1989 Jul; 72(3):439-44. PubMed ID: 2788455
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation.
Tichelli A; de Latour RP; Passweg J; Knol-Bout C; Socié G; Marsh J; Schrezenmeier H; Höchsmann B; Bacigalupo A; Samarasinghe S; Rovó A; Kulasekararaj A; Röth A; Eikema DJ; Bosman P; Bader P; Risitano A; Dufour C;
Haematologica; 2020 May; 105(5):1223-1231. PubMed ID: 31582549
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors for response to anti-thymocyte globulin in acquired aplastic anemia.
Hunter RF; Roth PA; Huang AT
Am J Med; 1985 Jul; 79(1):73-8. PubMed ID: 3874546
[TBL] [Abstract][Full Text] [Related]
16. Treatment of severe aplastic anemia with high-dose methylprednisolone and antilymphocyte globulin.
Marmont AM; Bacigalupo A; Van Lint MT; Frassoni F; Podesta M; Reali G; Piaggio G
Prog Clin Biol Res; 1984; 148():271-87. PubMed ID: 6379665
[TBL] [Abstract][Full Text] [Related]
17. Effect of antilymphocyte globulin (ALG) on bone marrow T/non-T cells from aplastic anaemia patients and normal controls.
Tong J; Bacigalupo A; Piaggio G; Figari O; Marmont A
Br J Haematol; 1989 Dec; 73(4):546-50. PubMed ID: 2692693
[TBL] [Abstract][Full Text] [Related]
18. Gender and response to antilymphocyte globulin (ALG) for severe aplastic anaemia.
Nissen C; Gratwohl A; Tichelli A; Stebler C; Würsch A; Moser Y; Dalle Carbonare V; Signer E; Buser M; Ritz R
Br J Haematol; 1993 Feb; 83(2):319-25. PubMed ID: 7681318
[TBL] [Abstract][Full Text] [Related]
19. Screening for paroxysmal nocturnal hemoglobinuria (PNH) clone in Egyptian children with aplastic anemia.
Rizk S; Ibrahim IY; Mansour IM; Kandil D
J Trop Pediatr; 2002 Jun; 48(3):132-7. PubMed ID: 12164595
[TBL] [Abstract][Full Text] [Related]
20. [Antilymphocyte globulin in the treatment of aplastic anemia].
Malesević M; Tukić L; Stamatović D; Trajković Z; Krstić C
Med Pregl; 1993; 46(7-8):291-5. PubMed ID: 7968829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
